Research Topics
Species | Anita DeswalSummaryAffiliation: Baylor College of Medicine Country: USA Publications
| Collaborators
|
Detail Information
Publications
Racial variations in quality of care and outcomes in an ambulatory heart failure cohortAnita Deswal
Houston Center for Quality of Care and Utilization Studies, Michael E DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX 77030, USA
Am Heart J 152:348-54. 2006..However, systematic evaluation of racial differences in both the quality of care and outcomes is needed in the outpatient setting, where most patients with HF are treated and where care may be more fragmented...
Results of the Randomized Aldosterone Antagonism in Heart Failure With Preserved Ejection Fraction Trial (RAAM-PEF)Anita Deswal
Winters Center for Heart Failure Research and Section of Cardiology, Michael E DeBakey VA Medical Center, Houston, TX 77030, USA
J Card Fail 17:634-42. 2011..By reducing cardiac fibrosis, aldosterone antagonists have the potential to be beneficial in heart failure with preserved ejection fraction (HFpEF)...
Comparison of morbidity in women versus men with heart failure and preserved ejection fractionAnita Deswal
Winters Center for Heart Failure Research, Section of Cardiology, Department of Medicine, Michael E DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA
Am J Cardiol 97:1228-31. 2006....
Diastolic dysfunction and diastolic heart failure: mechanisms and epidemiologyAnita Deswal
Michael E DeBakey VA Medical Center 152, 2002 Holcombe Boulevard, Houston, TX 77030, USA
Curr Cardiol Rep 7:178-83. 2005..Studies that further our understanding of mechanisms underlying diastolic dysfunction and diastolic HF will provide potential new targets for development of effective therapies for these conditions...
Impact of race on health care utilization and outcomes in veterans with congestive heart failureAnita Deswal
Houston Center for Quality of Care and Utilization Studies, Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas 77030, USA
J Am Coll Cardiol 43:778-84. 2004....
The metabolic syndrome and mortality in an ethnically diverse heart failure populationSaamir A Hassan
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
J Card Fail 14:590-5. 2008..Similar data are not available for a heart failure (HF) population. This study sought to determine the prevalence of the MetS and its effect on mortality in a HF population...
Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitusDavid Aguilar
Winters Center for Heart Failure Research and Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
Am J Cardiol 105:373-7. 2010..68, 95% confidence interval 1.26 to 2.25, p <0.001). In conclusion, in patients with HF and preserved LVEF, diabetes is associated with significantly increased risk of developing adverse HF outcomes...
Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fractionSameer Ather
Baylor College of Medicine, Houston, Texas, USA
J Am Coll Cardiol 59:998-1005. 2012....
Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failureAmandeep S Dhaliwal
Section of Cardiology, Department of Medicine, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
Am J Cardiol 104:270-5. 2009..Thus, background beta-blocker therapy appears to be protective against the potential harmful effects of alpha(1)-adrenergic antagonist therapy in patients with HF...
Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathyKumudha Ramasubbu
Winters Center for Heart Failure Research, Department of Medicine, Baylor College of Medicine and the Texas Heart Institute at St Luke s Episcopal Hospital, Houston, Texas 77030, USA
J Am Coll Cardiol 51:415-26. 2008..This review will examine the potential benefits of statins in HF patients with ischemic and nonischemic cardiomyopathy as well as potential concerns regarding the use of statins in these patients...
Long-term results of coronary artery bypass grafting in patients with ischemic cardiomyopathy: the impact of renal insufficiency and noncardiac vascular diseaseErnesto R Soltero
Section of Cardiothoracic Surgery, Operative Care Line, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX, USA
J Card Fail 11:206-12. 2005..These comorbid factors should be given important consideration when evaluating the risks and benefits of CABG...
The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failureDavid Aguilar
Winters Center for Heart Failure Research and Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas 77030, USA
J Am Coll Cardiol 50:32-6. 2007..This study sought to examine the relationship between thiazolidinedione (TZD) use and outcomes in ambulatory patients with diabetes and heart failure (HF)...
Metformin use and mortality in ambulatory patients with diabetes and heart failureDavid Aguilar
Winters Center for Heart Failure Research and Section of Cardiology, Department of Medicine, Baylor College of Medicine, 1709 Dryden Street, Houston, TX 77030, USA
Circ Heart Fail 4:53-8. 2011..We sought to compare the association between metformin use and clinical outcomes in a cohort of ambulatory patients with diabetes and established HF...
Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationshipSameer Ather
Baylor College of Medicine, Houston, TX, USA
Am Heart J 161:567-73. 2011..However, it is not known whether there is a ceiling beyond which high SBP has a detrimental effect. Thus, our aim was to assess the linearity of association between SBP and mortality...
New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients-a matter of time for contractilityBiykem Bozkurt
Section of Cardiology, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas Winters Center for Heart Failure Research, Baylor College of Medicine, Houston, Texas
J Card Fail 18:183-93. 2012..We aimed to examine whether the observed improvement in LVEF following carvedilol treatment is due to changes in intrinsic myocardial contractility beyond changes in LV chamber size or loading conditions...
Reduction in BNP levels with treatment of decompensated heart failure and future clinical eventsAmandeep S Dhaliwal
Section of Cardiology, Department of Medicine, Michael E DeBakey VA Medical Center, Houston, Texas 77030, USA
J Card Fail 15:293-9. 2009..We sought to compare the relationship between absolute and relative changes in BNP with future clinical events, and whether serial BNP measurements add prognostic information in patients treated for decompensated HF...
Role and optimal dosing of angiotensin-converting enzyme inhibitor therapyDhruv Kazi
Baylor College of Medicine, Houston, TX 77030, USA
Heart Fail Clin 1:25-37. 2005
Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fractionIldiko Agoston
Division of Cardiology, University of Texas Medical Branch, Galveston, Texas, USA
Am J Cardiol 94:1003-7. 2004..This underscores the importance of evaluating other agents for the treatment of patients who have HF-PEF...
Depression and anxiety in ambulatory patients with heart failureJeffrey A Cully
Houston Center for Quality of Care and Utilization Studies, Health Services Research and Development Service, Michael E DeBakey Veterans Affairs Medical Center, Houston, TX, USA
Psychosomatics 50:592-8. 2009..Depression and anxiety are common in heart failure, but the prevalence, incidence, and relationship of these conditions to health service use and mortality remains uncertain...
Biomarkers of inflammation in heart failureBiykem Bozkurt
Section of Cardiology, 3C 306A, Michael E DeBakey V A Medical Center, Houston, TX, 77030, USA
Heart Fail Rev 15:331-41. 2010..This review will focus on the emerging role of inflammatory biomarkers, including pro-inflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with HF...
Echocardiographic Changes During Treatment of Acute Decompensated Heart Failure: Insights From the ESCAPE TrialKumudha Ramasubbu
Department of Cardiology, Michael E DeBakey Veterans Administration Medical Center, Baylor College of Medicine, Houston, Texas Electronic address
J Card Fail 18:792-8. 2012..However, it is unknown whether sizes of cardiac chambers acutely change during HF therapy and whether these changes are associated with favorable clinical outcomes...
Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of heart failureArunima Misra
Winters Center for Heart Failure Research, Department of Medicine, Baylor College of Medicine, VA Medical Center, Houston, TX 77030, USA
Heart Fail Monit 3:42-8. 2002..This review highlights the currently available data on the epidemiology, pathophysiology, diagnosis, and treatment of asymptomatic LV systolic dysfunction...
New predictive models of heart failure mortality using time-series measurements and ensemble modelsDevika Subramanian
Department of Computer Science, Rice University, Houston, TX 77005, USA
Circ Heart Fail 4:456-62. 2011..Despite this, most multivariate predictive models for heart failure mortality have predictive accuracies characterized by a C-statistic (area under the receiver operating curve) of ≈0.74...
Obesity as a prognostic factor in chronic symptomatic heart failureBiykem Bozkurt
Department of Medicine, Baylor College of Medicine, Houston, TX, USA
Am Heart J 150:1233-9. 2005..Obesity is considered as an independent risk factor for development of heart failure (HF); however, its role in the progression of HF independent of atherosclerotic heart disease, hypertension, and diabetes is not well described...
Translation of clinical trial results into practice: temporal patterns of beta-blocker utilization for heart failure at hospital discharge and during ambulatory follow-upParag Patel
Department of Medicine, Baylor College of Medicine, Houston, TX, USA
Am Heart J 153:515-22. 2007..We examined recent temporal patterns of beta-blocker utilization in HF with systolic dysfunction at hospital discharge and over 2-year follow-up...
Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failureHector A Malave
Winters Center for Heart Failure Research, Houston, TX 77030, USA
Chest 123:716-24. 2003....
The July effect and cardiac surgery: the effect of the beginning of the academic cycle on outcomesAmandeep S Dhaliwal
Division of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
Am J Surg 196:720-5. 2008..The effect of the time of the academic year on cardiac surgical outcomes is unknown...
Advances in the treatment of heart failure with a preserved ejection fractionAparajita Das
Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
Curr Opin Cardiol 23:233-40. 2008..Therefore, there exists an urgent need to develop effective treatment strategies specifically for patients with HF-PEF. Recently completed and ongoing research in the treatment of HF-PEF is reviewed in this article...
Perils of the random experimentLemuel A Moye
University of Texas School of Public Health, RAS Building E815, 1200 Herman Pressler, Houston, TX 77030, USA
Am J Ther 10:112-21. 2003..Readers of clinical trial results must be vigilant for nonprotocol-driven research and understand that the results from these programs are at best exploratory and cannot be used to answer scientific questions...
The fragility of cardiovascular clinical trial resultsLemuel A Moye
University of Texas School of Public Health, Houston, Texas 77030, USA
J Card Fail 8:247-53. 2002..Clinical trials that have their prospective analysis plan altered are difficult to interpret...
Relationship of hemoglobin A1C and mortality in heart failure patients with diabetesDavid Aguilar
Winters Center for Heart Failure Research and Section of Cardiology, Department of Medicine, Baylor College of Medicine, 1709 Dryden Street BCM 620, Suite 500, Box 13, Houston, Texas 77030, USA
J Am Coll Cardiol 54:422-8. 2009..This study was designed to examine the relationship between glycosylated hemoglobin (HbA1C) and adverse outcomes in diabetic patients with established heart failure (HF)...
Variation by race in factors contributing to heart failure hospitalizationsHardeep Singh
Medical Care Line, VA Medical Center and Baylor College of Medicine, Houston, Texas, USA
J Card Fail 11:23-9. 2005..These findings may partly account for better long-term survival after hospitalization in black patients compared with white patients...
New therapeutics for chronic heart failureDouglas L Mann
Winters Center for Heart Failure Research, Department of Medicine, Baylor College of Medicine, 6565 Fannin Street, Houston, Texas 77030, USA
Annu Rev Med 53:59-74. 2002..We review the rationale for existing heart failure therapies and discuss the reasoning behind the development of some emerging therapies...
Anti-angiotensin therapy: new perspectivesKumudha Ramasubbu
Micheal E DeBakey Veterans Affairs Medical Center, Houston, TX, USA
Cardiol Clin 25:573-80; vi-vii. 2007..This article examines the rationale and role of ARBs in the treatment of patients with heart failure on the basis of evidence from clinical trials...
Recognition and treatment of depression and anxiety symptoms in heart failureJeffrey A Cully
Houston Center for Quality of Care and Utilization Studies, Health Services Research and Development Service, Michael E DeBakey Veterans Affairs Medical Center, Houston, Texas, USA
Prim Care Companion J Clin Psychiatry 11:103-9. 2009..The aim of this prospective study was to examine the prevalence, recognition, and treatment of depression and anxiety in ambulatory patients with heart failure...
Decreasing body temperature predicts early rehospitalization in congestive heart failureAmany Ahmed
Texas Heart Institute at St Luke s Episcopal Hospital, Houston, Texas 77030, USA
J Card Fail 14:489-96. 2008..In congestive heart failure (CHF), a low body temperature at hospital admission predicts in-hospital mortality. We hypothesized that a postdischarge reduction in body temperature predicts early CHF rehospitalization and death...
Angiotensin-receptor blockade in acute myocardial infarction--a matter of doseDouglas L Mann
N Engl J Med 349:1963-5. 2003
Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failureEric M Wilson
Cardiothoracic Surgery, Medical University of South Carolina, Charleston, South Carolina 29425, USA
J Card Fail 8:390-8. 2002..These changes in MMP/TIMP levels likely reflect the progression and/or acceleration of the LV remodeling process in CHF. Thus serial measurements of plasma MMP/TIMP levels may hold diagnostic/prognostic significance in CHF patients...
Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failureDhruv Kazi
Division of Cardiology, University of California, 200 W Arbor Drive, MPF 360, San Diego, CA 92103, USA
Cardiol Clin 26:1-14, v. 2008..Attempts should be made to up titrate patients to target doses of ACE inhibitors that have been used in clinical trials, if tolerated...
